Junji Koizumi

4.7k citations

83 papers · 3.7k indexed · 1 hit paper · h-index 27

Surgery top 1%
Endocrinology, Diabetes and Metabolism top 0.5%
Molecular Biology top 10%
Cancer Research top 2%
Cardiology and Cardiovascular Medicine top 5%

Co-authors: Hiroshi Mabuchi Akihiro Inazu Ryoyu Takeda Luis B. Agellon Alan R. Tall Maryanne L. Brown C B Hesler Susumu Miyamoto
Topics: Lipoproteins and Cardiovascular Health (47 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers)Cholesterol and Lipid Metabolism (17 papers)
Cited by: Endocrinology, Diabetes and Metabolism Surgery Cancer Research
Journals: Nature New England Journal of Medicine Journal of Biological Chemistry
Partner nations: Japan United States Australia

In The Last Decade

Junji Koizumi

81 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation

1990 687 citations Akihiro Inazu, Junji Koizumi et al. profile →

Peers

Countries citing papers authored by Junji Koizumi

Since Specialization

Citations

This map shows the geographic impact of Junji Koizumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Koizumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Koizumi more than expected).

Fields of papers citing papers by Junji Koizumi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Koizumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Koizumi. The network helps show where Junji Koizumi may publish in the future.

Co-authorship network of co-authors of Junji Koizumi

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Koizumi. A scholar is included among the top collaborators of Junji Koizumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Koizumi. Junji Koizumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia 2015 ·JIMD Reports ·Masa‐aki Kawashiri,Hayato Tada,(unknown),Matsuo Taniyama,Takamitsu Nakano,Katsuyuki Nakajima,Takeshi Inoue,Mika Mori,Chiaki Nakanishi,Tetsuo Konno,Kenshi Hayashi,Atsushi Nohara,Akihiro Inazu,Junji Koizumi,(unknown),Junji Kobayashi,Tsutomu Hirano,Hiroshi Mabuchi,Masakazu Yamagishi	11
2	Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation 2014 ·Atherosclerosis ·Hiroshi Mabuchi,Atsushi Nohara,Tohru Noguchi,Junji Kobayashi,Masa‐aki Kawashiri,Takeshi Inoue,Mika Mori,Hayato Tada,Chiaki Nakanishi,Kunimasa Yagi,Masakazu Yamagishi,Kousei Ueda,Tadayoshi Takegoshi,Susumu Miyamoto,Akihiro Inazu,Junji Koizumi	64
3	Gender differences in preferences for mentoring styles and topics in academic medicine in Japan 2014 ·(unknown),Ken Sakushima,Ken‐ei Sada,Junji Koizumi,(unknown),Naoto Kobayashi,Masaharu Nishimura,Junichiro Mori,Hirofumi Makino,Mitchell D. Feldman,Shunichi Fukuhara	2
4	Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects 2011 ·Clinica Chimica Acta ·(unknown),Akihiro Inazu,Yoshihiro Noji,Takanobu WAKASUGI,Kenji Miwa,Hayato Tada,Masa‐aki Kawashiri,Tohru Noguchi,Atsushi Nohara,Junji Kobayashi,Junji Koizumi,Masakazu Yamagishi,Hiroshi Mabuchi	12
5	Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan 2010 ·Atherosclerosis ·Hiroshi Mabuchi,Atsushi Nohara,Tohru Noguchi,Junji Kobayashi,Masa‐aki Kawashiri,Hayato Tada,Chiaki Nakanishi,Mika Mori,Masakazu Yamagishi,Akihiro Inazu,Junji Koizumi	82
6	Reduction of Serum Ubiquinol-10 and Ubiquinone-10 Levels by Atorvastatin in Hypercholesterolemic Patients 2005 ·Journal of Atherosclerosis and Thrombosis ·Hiroshi Mabuchi,Toshinori Higashikata,Masa‐aki Kawashiri,Shoji Katsuda,Mihoko Mizuno,Atsushi Nohara,Akihiro Inazu,Junji Koizumi,Junji Kobayashi	97
7	Association of coronary artery ectasia with plasma insulin levels in Japanese men of heterozygous familial hypercholesterolemia with the low-density lipoprotein receptor gene mutation K790X 2005 ·Clinica Chimica Acta ·Yuko Murase,Kunimasa Yagi,Junji Kobayashi,Atsushi Nohara,Akimichi Asano,Junji Koizumi,Hiroshi Mabuchi	2
8	Long-Term Course of Lipoprotein Lipase (LPL) Deficiency Due to Homozygous LPL_Aritain a Patient with Recurrent Pancreatitis, Retained Glucose Tolerance, and Atherosclerosis 2005 ·The Journal of Clinical Endocrinology & Metabolism ·Masa‐aki Kawashiri,Toshinori Higashikata,Mihoko Mizuno,(unknown),Shoji Katsuda,Kenji Miwa,Tsuyoshi Nozue,Atsushi Nohara,Akihiro Inazu,Junji Kobayashi,Junji Koizumi,Hiroshi Mabuchi	30
9	Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial 2004 ·International Journal of Cardiology ·Masami Shimizu,Junji Koizumi,Susumu Miyamoto,Hideki Origasa,Hiroshi Mabuchi	4
10	Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia 2000 ·The American Journal of Cardiology ·Masa‐aki Kawashiri,Kouji Kajinami,Atsushi Nohara,Kunimasa Yagi,Akihiro Inazu,Junji Koizumi,Hiroshi Mabuchi	25
11	Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia 2000 ·The American Journal of Cardiology ·Kouji Kajinami,Junji Koizumi,Kosei Ueda,Susumu Miyamoto,Tadayoshi Takegoshi,Hiroshi Mabuchi	64
12	Cholesteryl ester transfer protein and atherosclerosis 2000 ·Current Opinion in Lipidology ·Akihiro Inazu,Junji Koizumi,Hiroshi Mabuchi	49
13	Enzyme immunoassay for cholesteryl ester transfer protein in human serum 1998 ·Clinica Chimica Acta ·(unknown),(unknown),(unknown),Akihiro Inazu,Junji Koizumi,Hiroshi Mabuchi,Kenji Chichibu	31
14	The effect of a new HMG CoA reductase inhibitor, BAY w 6228, in combination therapy with colestyramine or probucol for familial hypercholesterolemia (FH) 1996 ·Junji Koizumi	1
15	Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia 1993 ·Atherosclerosis ·Junji Koizumi,(unknown),(unknown),Akihiro Inazu,(unknown),Tatsuo Haraki,Kunimasa Yagi,(unknown),Susumu Miyamoto,Tadayoshi Takegoshi,Hiroshi Mabuchi,Ryoyu Takeda,Nobutaka Tani,Satoshi Takada	36
16	Mutations in the Low Density Lipoprotein Receptor Gene in Japanese Patients with Familial Hypercholesterolemia 1990 ·Annals of the New York Academy of Sciences ·Hiroshi Mabuchi,Kouji Kajinami,Hajime Fujita,Junji Koizumi,Ryoyu Takeda	2
17	A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency 1989 ·Metabolism ·Hiroshi Mabuchi,Hideaki Itoh,Mitsuaki TAKEDA,Kouji Kajinami,Takanobu WAKASUGI,Junji Koizumi,Ryoyu Takeda,Chidori Asagami	58
18	Diagnostic Criteria for Familial Hypercholesterolemia in Japan 1977 ·Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·Hiroshi Mabuchi,Ryozo Tatami,Kosei Ueda,Ryosei Ueda,Toshihiro Haba,Tomio KAMETANI,Seigo Ito,Junji Koizumi,Susumu Miyamoto,(unknown),Ryoyu Takeda,Tadayoshi Takegoshi	3
19	Studies on the Diagnosis of Type III Hyperlipoproteinemia A suggestion of chemical criteria based on VLDL-cholesterol and VLDL-cholesterol/VLDL-triglyceride 1977 ·Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·Hiroshi Mabuchi,Kosei Ueda,Ryosei Ueda,Ryozo Tatami,Toshihiro Haba,Tomio KAMETANI,Seigo Ito,Junji Koizumi,(unknown),Susumu Miyamoto,Ryoyu Takeda	4
20	Achilles Tendon Thickness of Familial and Secondary Hypercholesterolemic Patients 1976 ·Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·Hiroshi Mabuchi,Seigo Ito,Toshihiro Haba,Tomio KAMETANI,Yukio Ueda,Junji Koizumi,(unknown),Susumu Miyamoto,Ryoyu Takeda,Tadayoshi Takegoshi	1

About Junji Koizumi

Junji Koizumi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research, having authored 83 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (47 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers) and Cholesterol and Lipid Metabolism (17 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Surgery (2.5k citations) and Cancer Research (808 citations). Junji Koizumi has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hiroshi Mabuchi, Akihiro Inazu, Ryoyu Takeda, Luis B. Agellon, Alan R. Tall, Maryanne L. Brown, C B Hesler, Susumu Miyamoto, Kouji Kajinami and Atsushi Nohara. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact